Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SingapOre Lung Cancer Screening Through Integrating CT With Other biomarkErs (SOLSTICE)

NCT05724264 is registered in ClinicalTrials.gov with National Cancer Centre, Singapore as lead sponsor.

NCT NCT05724264
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05724264 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SingapOre Lung Cancer Screening Through Integrating CT With Other biomarkErs (SOLSTICE)
Lead sponsor
National Cancer Centre, Singapore
Phase
Not applicable
Overall status
Recruiting
Start date
July 21, 2022
Completion date
December 31, 2029
Enrollment
1,000 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer